• GSK J4 HCl: Decoding H3K27 Biology

  2026-09-14

  Explore how GSK J4 HCl, a cell-permeable JMJD3 inhibitor, can clarify H3K27-dependent transcription and inflammatory signaling. This article connects product pharmacology with the hCG–CXCL10 decidual model to improve assay interpretation and experimental design.

• GSK J4 HCl: Reliable JMJD3 Assay Design

  2026-09-13

  Learn how GSK J4 HCl (SKU A4190) can be incorporated into cell viability, inflammatory, proliferation, and epigenetic workflows without confusing metabolic readouts with cell number. This scenario-based guide covers mechanism, controls, dosing interpretation, formulation, and practical supplier selection.

• Patient-Derived 3D Spheroids for Prostate Cancer

  2026-09-12

  Linxweiler and colleagues developed viable three-dimensional spheroid cultures directly from radical prostatectomy specimens, creating a translational model for organ-confined prostate cancer. The cultures retained key prostate epithelial and tumor markers, could be cryopreserved, and showed differential responses to androgen receptor-directed drugs, although their drug-response results require careful interpretation outside the ex vivo setting.

• Dual HER2–VEGFR-2 Targeting in TNBC

  2026-09-11

  The 2026 reference study evaluates Lapatinib and Telatinib as a dual tyrosine kinase inhibition strategy in HER2-negative MDA-MB-231 triple-negative breast cancer cells. Its main contribution is phenotype-first evidence linking treatment with reduced invadopodia formation, proliferation, and two-dimensional tube formation, while also exposing the difficulty of assigning target-specific mechanisms in receptor-negative models.

• Doxorubicin Beyond the Benchmark

  2026-09-11

  Doxorubicin remains a foundational DNA-damage tool, but its greatest translational value emerges when researchers connect mechanism, model selection, senescence biology, and assay strategy without confusing adjacent evidence with direct validation.

• LLY-507 Workflows for SMYD2 Inhibition Research

  2026-09-10

  LLY-507 combines nanomolar biochemical potency with strong SMYD2 selectivity, making it useful for separating target engagement from downstream cancer phenotypes. This guide translates its mechanism into reproducible methyltransferase, proliferation, apoptosis, and fibrosis-oriented workflows while clearly distinguishing product data from preclinical evidence.

• Arachidonic Acid and Faster Vaccine Immunity

  2026-09-10

  A 2025 EMBO Molecular Medicine study found that dietary arachidonic acid (ARA) accelerated and strengthened rabies vaccine-induced neutralizing antibody responses in mice and human volunteers. Its mechanistic experiments connect ARA-derived prostaglandin I2 to cAMP–PKA signaling, CD86 expression, and activation-induced cytidine deaminase in B cells, suggesting a dietary route for enhancing germinal-center humoral immunity.

• InstaBlue Protein Stain Solution: Fast Gel Staining

  2026-09-09

  InstaBlue Protein Stain Solution provides rapid Coomassie-based visualization of protein bands in polyacrylamide gels without fixation, washing, or destaining. It is useful for routine protein electrophoresis analysis and workflows that may proceed to mass spectrometry, but it should not replace a validated fixation method when methanol-based processing is specifically required.

• DOPE Beyond Delivery: Lipid Mechanisms in Translation

  2026-09-09

  1,2-Dioleoyl-sn-glycero-3-PE (DOPE) is best known as a helper phospholipid for endosomal escape, but emerging fungal biology shows how phosphatidylethanolamine availability can also become a mechanistic variable in ferroptotic cell death. This article connects delivery formulation strategy with the study of Magnaporthe oryzae conidial development, while defining the evidence boundaries, experimental controls, and translational opportunities for DOPE research.

• FLCN Mutations and mRNA Rescue in BHD Syndrome

  2026-09-08

  A 2026 study identified a novel FLCN nonsense variant and generated functional evidence that the previously uncertain p.W376R variant is pathogenic in two Chinese Birt-Hogg-Dubé families. In HEK293T cells, synthetic FLCN mRNA restored folliculin expression and reduced mTORC1 dysregulation, providing preliminary support for mRNA-based protein replacement while leaving delivery and in vivo efficacy unresolved.

• Coelenterazine as a Translational ROS Lens

  2026-09-08

  Coelenterazine is more than a luminescent enzyme substrate: used with disciplined controls, it can connect luciferase reporting, oxidative stress measurement, and cancer-associated reactive oxygen species imaging. This thought-leadership guide shows how translational researchers can extend brain–kidney AVP-axis research without confusing reporter activity with direct ROS biology.

• PP 2 (AG 1879): A Src Signaling Decision Tool

  2026-09-07

  PP 2 (AG 1879) is more than a Src inhibitor listing: it is a mechanistic probe for connecting kinase activity with cytoskeletal remodeling, cancer phenotypes, and immune signaling. This article shows how translational researchers can use it with pathway-aware controls, orthogonal validation, and disciplined interpretation.

• circRNA–FXR/TLR4 Signaling in NiONP Fibrosis

  2026-09-07

  This 2025 study identifies hsa_circ_0001944 as a regulator of the FXR/TLR4 axis and ferroptosis in nickel oxide nanoparticle-induced collagen deposition by LX-2 hepatic stellate cells. Its pharmacological and genetic experiments connect non-coding RNA regulation with nuclear receptor signaling and oxidative cell-death biology, while also defining important limits for translating the findings beyond cell and animal models.

• Berberine Hydrochloride in Inflammation Workflows

  2026-09-05

  Build reproducible Berberine hydrochloride assays for AMPK, LDLR, apoptosis, ferroptosis, and inflammatory readouts without confusing metabolic activity with direct inflammasome inhibition. This workflow connects validated product handling with the oxidized self-DNA–NLRP3 framework reported in acute kidney injury research.

• RPS6 Readouts in PDAC: From Membranes to Translation

  2026-09-04

  A translational framework for using RPS6 detection to connect the LRRC8A–CAV1 membrane axis with ribosome biogenesis, oncogenic signaling, and biosynthetic growth in pancreatic ductal adenocarcinoma. The article positions the Anti-RPS6 (7B10) Mouse Monoclonal Antibody as a versatile research tool while distinguishing total RPS6 abundance from phosphorylation-specific pathway activation.

3628 records 1/242 page Next 12345 下5页 Last page